{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:48:00Z","timestamp":1764402480958},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1002\/jps.22398","type":"journal-article","created":{"date-parts":[[2010,11,24]],"date-time":"2010-11-24T18:03:31Z","timestamp":1290621811000},"page":"1727-1735","source":"Crossref","is-referenced-by-count":7,"title":["Physicochemical Properties and Antifungal Activity of Amphotericin B Incorporated in Cholesteryl Carbonate Esters"],"prefix":"10.1016","volume":"100","author":[{"given":"Rabkwan","family":"Chuealee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy Scott","family":"Wiedmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teerapol","family":"Srichana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.22398_bb0005","series-title":"Antimicrobial agents: Antibacterials and antifungals","first-page":"1288","author":"Bryskier","year":"2005"},{"key":"10.1002\/jps.22398_bb0010","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF01962595","article-title":"Treatment of systemic fungal infections: Recent progress and current problems","volume":"7","author":"Walsh","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1002\/jps.22398_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00325481.1990.11716368","article-title":"Amphotericin B: Still the \u2018gold standard\u2019 for antifungal therapy","volume":"88","author":"Sarosi","year":"1990","journal-title":"Postgrad Med"},{"key":"10.1002\/jps.22398_bb0020","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","article-title":"Antifungal and surgical treatment of invasive fungal aspergillosis: Review of 2121 published cases","volume":"12","author":"Denning","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1002\/jps.22398_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-5173(88)90107-X","article-title":"A stability study of amphotericin B in aqueous media using factorial design","volume":"44","author":"Hung","year":"1988","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22398_bb0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(03)00342-9","article-title":"Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nanosphere","volume":"263","author":"Fukui","year":"2003","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22398_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps010310","article-title":"Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form","volume":"1","author":"Baas","year":"1999","journal-title":"AAPS PharmSci"},{"key":"10.1002\/jps.22398_bb0040","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/AAC.49.7.3028-3030.2005","article-title":"Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary Aspergillosis","volume":"49","author":"Gavald\u00e0","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.22398_bb0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-3062.2007.00209.x","article-title":"Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: A retrospective study","volume":"9","author":"Lowry","year":"2007","journal-title":"Transplant Infect Dis"},{"key":"10.1002\/jps.22398_bb0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.healun.2009.11.603","article-title":"Feasibility, tolerability and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation","volume":"29","author":"Monforte","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1002\/jps.22398_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10717540490467375","article-title":"Development of liposomal amphotericin B dry powder inhaler formulation","volume":"11","author":"Shah","year":"2004","journal-title":"Drug Deliv"},{"key":"10.1002\/jps.22398_bb0060","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1023\/B:PHAM.0000045237.46019.6e","article-title":"Supercooled smectic nanoparticles: A potential novel carrier system for poorly water soluble drugs","volume":"21","author":"Kuntsche","year":"2004","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22398_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0168-3659(96)01321-1","article-title":"Development and investigation of a thermo-responsive cholesteryl oleyl carbonate-embedded membrane","volume":"41","author":"Lin","year":"1996","journal-title":"J Control Release"},{"key":"10.1002\/jps.22398_bb0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1023\/A:1008959325997","article-title":"Effect of skin-penetrating enhancers on the thermophysical properties of cholesteryl oleyl carbonate embedded in a thermo-responsive membrane","volume":"11","author":"Lin","year":"2000","journal-title":"J Mater Sci Med"},{"key":"10.1002\/jps.22398_bb0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1557\/JMR.2009.0027","article-title":"Thermotropic phase behavior of sodium cholesteryl carbonate","volume":"24","author":"Chuealee","year":"2009","journal-title":"J Mater Res"},{"key":"10.1002\/jps.22398_bb0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/jps.1042","article-title":"Formulation and characterization of amphotericin B\u2013polyethylenimine-dextran sulfate nanoparticles","volume":"90","author":"Tiyaboonchai","year":"2001","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22398_bb0085","series-title":"Surfactants and polymers in drug delivery","first-page":"19","author":"Malmsten","year":"2002"},{"key":"10.1002\/jps.22398_bb0090","series-title":"Antibiotics in laboratory medicine","first-page":"226","article-title":"Antifungal drugs: Mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biological fluids","author":"Pfaller","year":"1996"},{"key":"10.1002\/jps.22398_bb0095","first-page":"125","article-title":"Application of spectrofluorometry for evaluation of dry powder inhalers in vitro","volume":"58","author":"Srichana","year":"2003","journal-title":"Pharmazie"},{"key":"10.1002\/jps.22398_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(98)00037-4","article-title":"On the relationship between drug and carrier deposition from dry powder inhalers in vitro","volume":"167","author":"Srichana","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.22398_bb0105","doi-asserted-by":"crossref","unstructured":"Lavasanifar A, Samuel J, Kwon GS. Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate-Laspartamide) by solvent evaporation method: Effect on the solubilization and haemolytic activity of amphotericin B. J Control Release 77:155\u2013160.","DOI":"10.1016\/S0168-3659(01)00477-1"},{"key":"10.1002\/jps.22398_bb0110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jac\/46.6.997","article-title":"Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents","volume":"46","author":"Aller","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.22398_bb0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jac\/45.5.645","article-title":"In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method","volume":"45","author":"L\u00f3pez-Jodra","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.22398_bb0120","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/JCM.34.4.842-847.1996","article-title":"Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test","volume":"34","author":"Van Eldere","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1002\/jps.22398_bb0125","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.50.4.1287-1292.2006","article-title":"Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.22398_bb0130","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1016\/j.tetlet.2007.03.058","article-title":"Amphotericin B covalent dimers with carbonyl-amino linkage: A new probe for investigating ion channel assemblies","volume":"48","author":"Umegawaa","year":"2007","journal-title":"Tetrahedron Lett"},{"key":"10.1002\/jps.22398_bb0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejps.2009.02.021","article-title":"Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics","volume":"37","author":"Jung","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.22398_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-409X(97)00510-3","article-title":"Review of dry powder inhalers","volume":"26","author":"Prime","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22398_bb0145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0021-8502(96)00021-3","article-title":"The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation","volume":"27","author":"French","year":"1996","journal-title":"J Aerosol Sci"},{"key":"10.1002\/jps.22398_bb0150","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards","year":"1997","journal-title":"Science"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491532150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491532150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T02:23:42Z","timestamp":1592101422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491532150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S002235491532150X"],"URL":"https:\/\/doi.org\/10.1002\/jps.22398","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}